Treace John T. - 08 Mar 2026 Form 4 Insider Report for TREACE MEDICAL CONCEPTS, INC. (TMCI)

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ Lisa Taylor as Attorney-in-fact for John Treace
Issuer symbol
TMCI
Transactions as of
08 Mar 2026
Net transactions value
$0
Form type
4
Filing time
11 Mar 2026, 21:00:04 UTC
Previous filing
23 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Treace John T. Chief Executive Officer, Director, 10%+ Owner C/O TREACE MEDICAL CONCEPTS, INC., 100 PALMETTO PARK PLACE, PONTE VEDRA /s/ Lisa Taylor as Attorney-in-fact for John Treace 11 Mar 2026 0001856380

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMCI Common Stock Tax liability -2,062 -0.03% $0.000000* 7,009,571 08 Mar 2026 Direct F1
transaction TMCI Common Stock Tax liability -5,021 -0.07% $0.000000* 7,004,550 10 Mar 2026 Direct F2
holding TMCI Common Stock 1,605,000 08 Mar 2026 By spouse F3
holding TMCI Common Stock 1,471,250 08 Mar 2026 By spouse as trustee of a trust F3
holding TMCI Common Stock 1,839,063 08 Mar 2026 As trustee of a trust F4
holding TMCI Common Stock 408,816 08 Mar 2026 As co-trustee of a trust F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 563,403 restricted stock units.
F2 Includes 542,784 restricted stock units.
F3 The Reporting Person disclaims beneficial ownership of shares held by his wife directly or in trusts for which his wife serves as trustee or co-trustee.
F4 The Reporting Person disclaims ownership of shares held in trust for which he serves as trustee or co-trustee.